Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
98599501000001119 | Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
98599601000001115 | Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) 60 tablet 4 x 15 tablets | Has AMP | True | Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier | |
Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets | Has AMP | True | Gliclazide 80mg tablets (Genesis Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets